Pharmaceutical Technology - February 2024

Pharmaceutical Technology - February 2024

Issue link: https://www.e-digitaleditions.com/i/1516147

Contents of this Issue

Navigation

Page 16 of 33

16 Pharmaceutical Technology ® Bio/Pharma Outsourcing Innovation eBook February 2024 PharmTech.com Dr_Microbe, Paulista - stock.adobe.com A ffinity ligands play an exciting role in the ev- er-growing sphere of downstream process- ing. In speaking with Pharmaceutical Tech- nology ® , Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, di- rector, Business Development, Commercial and Tech- nical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing. Breaking down affinity ligands PharmTech: What are affinity ligands and how do they contribute to the downstream purification process? Bekker (BioCina): Affinity ligands are molecules that can bind with high affinity to specific targets. Affinity ligands can be used for various purposes, such as detec- tion, purification, or modulation of biological activities. Affinity chromatography is a separation method based on the specific binding interaction between an immo- bilized affinity ligand and its binding partner. The most common example in the realm of bioprocessing is Pro- tein A, which has an extremely high affinity for some immunoglobulin molecules. Other examples include antibody/antigen, enzyme/substrate, and enzyme/in- hibitor interactions. The degree of purification achieved by affinity purification can be quite high depending on the specificity of the interaction. Consequently, it is gen- erally the first step in a purification strategy. Release of the protein from the ligand is generally achieved by altering parameters such as pH, and so- dium chloride concentration or by the addition of a competitor for ligand binding. Shamlou (Abzena): In nature, there is a vast array of biomolecule interactions where binding of one molecule to another through receptor–ligand interac- tions is critical for biological function. This concept is A Closer Look at Affinity Ligands Daria Husni is assistant editor to Pharmaceutical Technology®. A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - February 2024 - Pharmaceutical Technology - February 2024